EcoDrugPlus

Melatonin Receptor 1a

Ensembl ID : ENSVVUG00000012211
Gene Symbol: MTNR1A
1 Cross references
205 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSVVUG00000024539
Gene Symbol: MME
2 Cross references
228 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSVVUG00000019091
Gene Symbol: METAP2
3 Cross references
213 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSVVUG00000005337
Gene Symbol: MAPT
3 Cross references
255 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSVVUG00000020374
Gene Symbol: MAPK1
3 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSVVUG00000013277
Gene Symbol: MAPK10
3 Cross references
147 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSVVUG00000025520
Gene Symbol: MAPK11
3 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSVVUG00000026201
Gene Symbol: MAPK14
3 Cross references
280 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSVVUG00000026001
Gene Symbol: MAPK3
2 Cross references
192 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSVVUG00000020911
Gene Symbol: MAPK8
3 Cross references
294 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSVVUG00000026948
Gene Symbol: MAPK9
3 Cross references
219 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 1

Ensembl ID : ENSVVUG00000014514
Gene Symbol: MAP2K1
1 Cross references
209 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).